Science Explorer Back to mapMap
Discussion
Company · Regensburg · Germany

Lophius Biosciences (Germany)

lophius.com/lophius.htmlROR OpenAlex
Research works
7
▼ 97% vs 2018-21
Citations
74
10.2 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
33%
world 40%
International
25%
world 18%
Lophius Biosciences (Germany)

Not ranked overall: Lophius Biosciences (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Lophius Biosciences (Germany) work in?

In all years, 54% of research at Lophius Biosciences (Germany) is in Life Sciences, 46% in Health Sciences. Its largest fields are Medicine (46%), Immunology and Microbiology (37%), Biochemistry, Genetics and Molecular Biology (12%). It does 1.7× the world's share of Life Sciences.

Life Sciences: 4 fractional works · 54.5% of its workImmunology and Microbiology: 3 fractional works · 37.0% of its workImmunology: 2 fractional works · 32.8% of its workVirology: 0 fractional works · 2.3% of its workParasitology: 0 fractional works · 1.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 12.3% of its workMolecular Biology: 1 fractional works · 7.9% of its workBiophysics: 0 fractional works · 2.3% of its workBiochemistry: 0 fractional works · 1.5% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 4.6% of its workAnimal Science and Zoology: 0 fractional works · 2.3% of its workPlant Science: 0 fractional works · 2.3% of its workNeuroscience: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workHealth Sciences: 3 fractional works · 45.5% of its workMedicine: 3 fractional works · 45.5% of its workEpidemiology: 2 fractional works · 24.7% of its workObstetrics and Gynecology: 0 fractional works · 6.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 4.6% of its workOncology: 0 fractional works · 2.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.3% of its workInfectious Diseases: 0 fractional works · 1.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workTransplantation: 0 fractional works · 1.0% of its workHepatology: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.3% of its workALL ITS WORKLophiusBiosciences…7fractional works, all years
Life Sciences54%Health Sciences46%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 5 fields, with their numbers
    1. Immunology and Microbiology337.0%
    2. Biochemistry, Genetics and Molecular Biology112.3%
    3. Agricultural and Biological Sciences04.6%
    4. Neuroscience00.7%
    1. Medicine345.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at Lophius Biosciences (Germany)?

Ranked on the quality score, Sascha Barabas lead among researchers whose main affiliation is Lophius Biosciences (Germany).

  1. 1 Sascha Barabas Germany · #3,680,278 worldwide 365 citations · 34 works
All ranked researchers at Lophius Biosciences (Germany)

What are the most cited papers from Lophius Biosciences (Germany)?

The most cited paper from Lophius Biosciences (Germany) is "An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity" (Sascha Barabas, Theresa Spindler, Richard Kiener et al., 2017), with 68 citations. Next come "4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease†" (67) and "Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation" (55).

Most cited papers
#PaperReleasedCitations
1 An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity Sascha Barabas, Theresa Spindler, Richard Kiener et al. · BMC Immunology Open access 7 Mar 2017 68
2 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease† Leo R. Fitzpatrick, Ludwig Deml, Claudia Hofmann et al. · Inflammatory Bowel Diseases 22 Mar 2010 67
3 Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation Eva Wagner-Drouet et al. · Haematologica Open access 26 Dec 2019 55
4 Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients Bernhard Banas, Carsten A. Böger, Gerhard Lückhoff et al. · BMC Immunology Open access 7 Mar 2017 40
5 Clinical validation of a novel enzyme-linked immunosorbent spot assay-basedin vitrodiagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study Bernhard Banas et al. · Transplant International Open access 28 Dec 2017 37
All 18 most cited papers, with filters and sorting

Which research topics does Lophius Biosciences (Germany) publish most on?

By volume in 2022-now: Infectious Diseases and Tuberculosis, Tuberculosis Research and Epidemiology and Mycobacterium research and diagnosis.

  1. 1 Infectious Diseases and Tuberculosis Surgery 0 works
  2. 2 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
  3. 3 Mycobacterium research and diagnosis Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.1%not open66.9%

World: 40% of research is openly available.

with international co-authors24.8%domestic only75.2%

World: 18% is written across borders.

How has Lophius Biosciences (Germany)'s research output changed?

Output in 2022-2025 was 97% lower than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Lophius Biosciences (Germany) as a percentage of every work published that year, 0.000016% in 2021.

0.000025%0.000050%0.000075%Lophius Biosciences (Germany)0.00000093% in 20232020

Fractional works of Lophius Biosciences (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Regensburg

All research institutions in Regensburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Lophius Biosciences (Germany). Posts are plain text and can be reported.